AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Trial details
- Registry ID
- NCT05693142
- Phase
- Phase 2, Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142 | RGNX | Phase 2, Phase 3 | Active not recruiting | 2026-09Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |